Xianghua Wu - Concepedia

Author

Xianghua Wu

Fudan University Shanghai Cancer Center ORCID

Also Known As

QingHua YAO, X Wu, X. Wu, XIANGHUA WU, Xi-Ai Wu, Xiang-Hua Wu, Xiang-hua Wu, Xianghua (Jason) Wu, Xianghua Wu, Xingting Wu

113

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Fudan University Shanghai Jiao Tong University Shanghai Cancer Institute

About

Xianghua Wu is an author at Fudan University Shanghai Cancer Center specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	561
2	Engineering	2	2	35
3	Health Sciences	2	2	24
4	Biomolecular Engineering	2	2	423
5	Biomedical Engineering	1	1	23

Xianghua Wu

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics Zonghai Li, Ruijiao Zhao, Xianghua Wu, The FASEB Journal Tumor XenograftsTargeted DeliveryPeptide EngineeringPeptide TherapeuticsDermatology	2005	412
Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma Qian Song, Jun Shang, Zuyi Yang, Journal of Translational Medicine	2019	197
Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy Kailin Xing, Bingxin Gu, Ping Zhang, BMC Immunology	2015	134
A phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: Armed oncolytic adenovirus for the treatment of head and neck cancers Jianhua Chang, Xiaoying Zhao, Xianghua Wu, Cancer Biology & Therapy	2009	87
USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51‐AKT1 signaling Xinmin Zhao, Xianghua Wu, Huijie Wang, Molecular Carcinogenesis	2020	42
Transcription factor RUNX3 promotes CD8<sup>+</sup> T cell recruitment by CCL3 and CCL20 in lung adenocarcinoma immune microenvironment Qian Song, Jun Shang, Chufan Zhang, Journal of Cellular Biochemistry	2020	41
Decreased expression of RPS15A suppresses proliferation of lung cancer cells Xinmin Zhao, Lei Shen, Yu Feng, Tumor Biology	2015	35
Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study Zhihuang Hu, Si Sun, Xinmin Zhao, The Oncologist	2022	35
Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study Xin Liu, Shiyu Jiang, Huijie Wang, Clinical Cancer Research	2022	35
A Phase II Study of Apatinib in Patients with Chemotherapy-Refractory Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11) Li Chu, Yun Chen, Qi Liu, The Oncologist	2021	33

Page 1